Provisional Patent Archives - Halberd Corporation

Aug 23 2021

Halberd Files Provisional Patent Application – Furthering Efforts on Alzheimer’s Disease

By Admin|2021-08-22T21:05:51-04:00August 23rd, 2021|Featured, Investor News, News|0 Comments

Jackson Center, PA, August 23, 2021 – Halberd Corp. (OTC PINK: "HALB") announced filing a U. S. joint provisional patent application, “Treating Alzheimer’s Disease Utilizing Extracorporeal Radio Frequency.” The innovation is a result of Halberd’s Sponsored Research conducted at Arizona State University (ASU) and Youngstown State University (YSU). The provisional patent application covers technology developed ...

Jun 1 2021

Halberd Corp. Files Provisional Patent Application Complementing Patented Extracorporeal Radio Frequency/Laser Projects

By Admin|2021-05-30T12:12:26-04:00June 1st, 2021|Featured, Investor News, News|0 Comments

Jackson Center, PA, June 1, 2021 – Halberd Corp. (OTC PINK: "HALB") announced the filing of a U. S. joint provisional patent application titled, “Antibody Conjugated Nanoparticle Assay And Treatment For SARS-CoV-2.” The innovation is a result of Halberd’s Sponsored Research conducted at Arizona State University (ASU). The provisional patent application covers technology developed to ...

Mar 18 2021

Halberd Corporation Files International Patent Cooperation Treaty (PCT) Application Covering Extracorporeal Treatment of COVID-19 and Other Medical Maladies

By Admin|2021-03-17T21:09:58-04:00March 18th, 2021|Featured, Investor News, News|0 Comments

Jackson Center, PA, March 18, 2021 – Halberd Corporation (OTC-PINK: "HALB") filed an International Patent Cooperation Treaty (PCT) application for coverage of the invention titled, “Method for Treating and Curing Covid-19 Infection.” The Patent Cooperation Treaty has over 150 participating countries and allows an inventor to seek patent protection in numerous countries simultaneously. William A. ...

Nov 19 2020

Halberd Corporation Files for Patent Protection on Covid-19 Extracorporeal Treatment Variation

By Admin|2020-11-18T19:10:48-05:00November 19th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, November 19, 2020 – Halberd Corp. (OTC PINK: "HALB") reported the filing of a provisional patent application on a variation of Halberd’s patented extracorporeal method to treat/eradicate Covid-19 from a patient’s blood. By using an extracorporeal (outside the body) treatment method, the patient is exposed to far fewer potential negative side effects ...